In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
Offering a combination of personalized customization, enhanced imaging quality and dose efficiency considerations, the Zenition 30 mobile C-arm device has garnered 510(k) clearance from the Food and Drug Administration (FDA).
Deemphasizing the need for manual adjustments, the Zenition 30 mobile C-arm device features automated adjustments to the preferred settings of clinicians and as well as accessible push buttons on the flat detector that allow necessary adjustments to horizontal, orbital and/or rotational positioning changes of the C-arm, according to Philips, the manufacturer of the Zenition 30 mobile C-arm device.
The Zenition 30 mobile C-arm device features automated adjustments to the preferred settings of clinicians as well as accessible push buttons on the flat detector that allow necessary adjustments to horizontal, orbital and/or rotational positioning changes of the C-arm. (Image courtesy of Philips.)
Philips noted that other features of the device include low-dose modes for pediatric patients, enhanced vascular imaging with digital subtraction angiography (DSA) procedures, and automated imaging adjustments with the Philips MetalSmart software that eliminate blooming in the imaging of patients with metal implants.
“Based on our Zenition platform’s proven ease of use and workflow efficiency, the new Zenition 30 offers a unique combination of personalized control and image clarity to enhance the speed and accuracy of decision making for a range of clinical procedures at a price point that meets today’s economic and business goals,” said Mark Stoffels, the general manager of Philips Image Guided Therapy Systems.
Can AI Facilitate Improved Dual-Energy X-Ray Screening for Patients at High Risk of Osteoporosis?
June 28th 2024Out of 315 patients identified by artificial intelligence (AI) as being at high risk for osteoporosis, subsequent screening with dual-energy X-ray absorptiometry (DXA) in a randomized controlled trial revealed new-onset osteoporosis in 237 patients.
FDA Clears Mobile C-Arm Device Designed for Complex Vascular Procedures
June 17th 2024Offering a combination of intuitive user-friendly controls and enhanced imaging, the Zenition 90 Motorized C-arm reportedly facilitates workflow efficiencies and bolsters visualization for complex vascular procedures, cardiac interventions, and other clinical procedures.
Qure.ai to Debut Multimodality AI Platform for Lung Cancer Imaging at ASCO 2024
May 29th 2024In addition to detecting missed lung nodules on X-rays, the AI-powered Qure.ai lung cancer continuum platform reportedly automates lung nodule measurement on CT scans and facilitates multimodality reporting.